NASS 2018 Annual Meeting
Tweet
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Buzz
Speakers
Kee
Kim, MD
Kee Kim, MD
Board of Directors: Molecular Matrix (205,000 shares); Consulting: Corentec (B), InVivo Therapeutics (B), Mirus (B), Vertex Pharmaceuticals (B), Zimmer Biomet (A); Grants: Empirical Spine (E, Paid directly to institution/employer), FzioMed (B, Paid directly to institution/employer), InVivo Therapeutics (F, Paid directly to institution/employer), Medtronic (C, Paid directly to institution/employer), Mesoblast (G, Paid directly to institution/employer), Orthofix (F, Paid directly to institution/employer), Pacira Pharmaceuticals (E, Paid directly to institution/employer), Seikagaku (C, Paid directly to institution/employer), Vertex Pharmaceuticals (F, Paid directly to institution/employer), Zimmer Biomet (E, Paid directly to institution/employer); Royalties: Globus (B), Precision Spine (D), Zimmer Biomet (E); Speaking and/or Teaching Arrangements: AOSpine (B).
Sessions :
Section on Motion Technology Abstract Presentations
Home
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Tweet
Login
|
Back to top
ChirpE